ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO362

Tubulointerstitial Nephritis and Uveitis Unmasked by Decreasing Anti-TNF Alpha

Session Information

Category: Trainee Case Report

  • 103 AKI: Mechanisms

Authors

  • Tio, Maria Clarissa, Brigham and Women's Hospital, Massachusetts General Hospital, Boston, Massachusetts, United States
  • Cheung, Pui Susan Wen, Massachusetts General Hospital, Boston, Massachusetts, United States
Introduction

Tubulo-interstitial nephritis and uveitis (TINU) is characterized by ocular and renal manifestations, and it could be associated with autoimmune, genetic, vascular, medication, and paraneoplastic etiologies. Here we present a case of TINU unmasked by decreasing anti-TNF alpha agent adalimumab.

Case Description

55-year-old Caucasian male with history of hypertension on lisinopril and psoriatic arthritis on adalimumab admitted for acute renal failure. Four weeks prior to admission, patient presented to the ophthalmology clinic with sudden onset and progressively worsening bilateral blurring of his vision with symptomatic central vision loss. At that time, he was found to have a localized macular detachment with yellow choroidal lesions, and managed conservative with weekly follow up. Notable recent medication change was dose reduction of adalimumab from 40mg to 20mg every other week in the past year due to improvement of joint symptoms. On the day of admission at ophthalmology clinic, he was found to have an increase in retinal fluid and bilateral serous detachment with yellow/white choroidal lesions in the peripheral macula and fovea consistent with atypical uveitis. Routine labs showed sCr 12.3mg/dL (baseline 1.1 mg/dL 4 months ago), K 7.1mEq/L, HCO3- 14mEq/L, BUN 80mg/dL. Urinalysis showed 1+ leukocyte esterase, no blood or protein, urine microscopy showed WBC clumps. Despite medical management, and robust urine output, repeat K was 8.5 mEq/L required emergent hemodialysis. He was also initiated on prednisone for concerns of acute interstitial nephritis. Renal biopsy revealed acute interstitial nephritis with mononuclear cells and focal clusters of eosinophils. Other serologies showed CRP 23.7mg/L, ACE <5U/L, Lysozyme 9.9mcg/mL, ANA positive at 1:160, speckled, IgG4 negative. CT was negative for malignancy. His vision improved significantly after the first dose of prednisone. HD was discontinued on day 4 of admission, and prednisone was tapered over months. Discharge sCr was 6.76mg/dL and 2 weeks post discharge was 1.8mg/dL.

Discussion

In patient with TINU, uveitis can present as vision loss without apparent inflammation, and it often presents separately from interstitial nephritis. This patient has atypical posterior uveitis and biopsy-proven AIN consistent with TINU, likely unmasked by tapering of adalimumab.